Rameen Beroukhim

Rameen Beroukhim is a Broad Institute computational cancer biologist and Dana-Farber faculty member, primarily an academic scientist whose angel activity is more about scientific co-founder and SAB-type roles than deep capital. His pattern is biotech and diagnostics, with small (<$25k) checks at pre-seed and seed. Boston-based. Best fit: deep-tech founders coming out of the Broad, Dana-Farber, or MIT/Harvard cancer-genomics ecosystem, with credible computational biology and genomics chops; founders who need a respected scientific name on the cap table or SAB more than they need a six-figure check. Honest read: this is functionally a credibility check, not a real funding round; do not over-index on him as a financial partner. Entry path is via the Broad Institute, Dana-Farber, or warm intros from his academic collaborators; LinkedIn is unlikely to land. Not a fit for digital health, devices, biotech outside oncology and genomics, or anyone who needs an active operating angel. If your story is a novel computational approach to cancer biology and you want a small but signal-rich check plus a scientific advisor, this is one of the right doors; if you need a $250k check, look at institutional seed funds with Beroukhim as a possible advisor instead.